Código QR (código de barras bidimensional)

Prognostic significance of galectin‐3 expression in patients with resected NSCLC treated with platinum‐based adjuvant chemotherapy

Abstract Background Galectin‐3 (GAL3), a protein encoded by the LGALS3 gene, plays diverse roles in cancer initiation, progression, and drug resistance. Accordingly, high GAL3 expression in tumor cells is associated with poor prognosis in non‐small cell lung cancer (NSCLC). However, the prognostic i...

תיאור מלא

שמור ב:
Principais autores: Seiichiro Kusuhara, Satoshi Igawa, Masaaki Ichinoe, Ryo Nagashio, Yuki Kuchitsu, Yasuhiro Hiyoshi, Kazu Shiomi, Yoshiki Murakumo, Makoto Saegusa, Yukitoshi Satoh, Yuichi Sato, Katsuhiko Naoki
פורמט: Artigo
שפה:Inglês
יצא לאור: Wiley 2021-05-01
סדרה:Thoracic Cancer
נושאים:
adjuvant chemotherapy
biomarker
galectin‐3
immunohistochemistry
non‐small cell lung cancer
גישה מקוונת:https://doi.org/10.1111/1759-7714.13945
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים